Survey Finds Hong Kong Cancer Patients Spend 62.5% of Household Income on Treatment
On.cc · 1 SOURCESabout 2 hours ago7 MIN
Summary
A survey released on Monday (September 28, 2026) by patient advocacy groups revealed that Hong Kong cancer patients are grappling with overwhelming financial burdens, with monthly self-funded treatment costs reaching a median of HK$13,500. The survey, conducted by the Coalition for Patients' Concerns and Medical Reform (長期病患者關注及醫療改革聯席) together with the Peer Alliance (同路人同盟), collected responses from 164 cancer patients currently undergoing treatment . The findings show that such expenses consume 62.5% of the median monthly household income of HK$30,000, with 42.7% of respondents spending an amount equal to or exceeding their entire family's monthly earnings . Alarmingly, 31.1% of patients admitted to extreme worry about being forced to discontinue their medication due to cost constraints, while the median financial stress score reached 8 out of 10 . Patient groups are urging the government to build a faster, more transparent, and affordable cancer treatment framework, including relaxing means-testing criteria for safety nets .
Key Points
- Survey of 164 cancer patients found median monthly self-funded cancer drug costs of HK$9,550, plus HK$4,000 for other medical expenses, totaling HK$13,500 or 62.5% of household income
- Nearly 70% of respondents primarily use public unfunded drugs, private unfunded drugs, or private medications, while only 20% rely on generic/subsidized drugs or fund assistance
- 34 respondents knew of more suitable medications but 23 ultimately gave up due to prohibitive costs, and 11 because the drugs were not registered or included in the formulary
- The economic impact extends across families: 73.8% said treatment exhausted household assets, 54.9% stopped working due to illness, and 10% had to borrow money to survive
- A lung cancer survivor identified as Ms. Liu highlighted that many patients miss the window for financial planning at diagnosis, calling on the government to ensure patients can both see and afford medication
Why It Matters
The survey exposes a systemic gap in Hong Kong's cancer care framework where patients face impossible choices between life-saving treatment and financial survival. With nearly one-third of patients worried about abandoning their medication regimen, the findings underscore the urgent need for policy reform to prevent treatment interruption and reduce cancer mortality rates. The broader economic consequences—depleted savings, lost income, and rising household debt—threaten to push more families into financial distress without meaningful government intervention.
The survey exposes a systemic gap in Hong Kong's cancer care framework where patients face impossible choices between life-saving treatment and financial survival. With nearly one-third of patients worried about abandoning their medication regimen, the findings underscore the urgent need for policy reform to prevent treatment interruption and reduce cancer mortality rates. The broader economic consequences—depleted savings, lost income, and rising household debt—threaten to push more families into financial distress without meaningful government intervention.